28314

506260

ANUHPHR

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ANUH PHARMA LIMITED Share Price Today

ANUH PHARMA LIMITED is currently trading at ₹77.65, down by ₹1.25 from the previous close. The stock touched an intraday high of ₹79.60 and a low of ₹76.50 during the latest trading session. Over the past one year, ANUH PHARMA LIMITED has delivered a loss of 25.3%, while the stock has declined 2.7% in the last one month.

ANUH PHARMA LIMITED performance

Today’s low Today’s high
₹ 76.50 ₹ 79.60
₹ 77.60
52 week low 52 week high
₹ 67.00 ₹ 114.84
₹ 77.60
Open Price ₹ 78.92
Prev. Close ₹ 78.90
Volume (Shares) 60966.00
Total traded value ₹ 47.30
Upper Circuit ₹ 94.68
Lower Circuit ₹ 63.12
info

Investment Returns

Over 1 Month -2.70% Over 3 Months 4.45% Over 6 Months -0.95% Over 1 Year -25.30%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ANUH PHARMA LIMITED fundamentals


  • Market cap (Cr) 777.70
  • P/E Ratio (TTM) 18.94
  • Beta 0.78
  • Book Value / share 35.14
  • Return on equity 13.41%
  • EPS (TTM) 4.10
  • Dividend yield 1.93%
  • Net profit/quarter (Cr) 11.68
info icon alternate text
  • Market cap (Cr) 778.10
  • P/E Ratio (TTM) 18.94
  • Beta 0.77
  • Book Value / share 35.14
  • Return on equity 13.41%
  • EPS (TTM) 4.10
  • Dividend yield 1.93%
  • Net profit/quarter (Cr) 11.68
info icon alternate text

ANUH PHARMA LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 202.12
Operating Expense 185.35
Net Profit 11.68
Net Profit Margin (%) 5.77
Earnings Per Share (EPS) 1.17
EBITDA 18.63
Effective Tax Rate (%) 24.74
Particulars DEC 2025 (Values in Cr)
Revenue 197.18
Operating Expense 181.14
Net Profit 13.45
Net Profit Margin (%) 6.82
Earnings Per Share (EPS) 1.34
EBITDA 20.90
Effective Tax Rate (%) 24.56
Particulars SEP 2025 (Values in Cr)
Revenue 185.88
Operating Expense 176.95
Net Profit 7.61
Net Profit Margin (%) 4.09
Earnings Per Share (EPS) 0.76
EBITDA 12.86
Effective Tax Rate (%) 23.28
Particulars JUN 2025 (Values in Cr)
Revenue 186.48
Operating Expense 178.91
Net Profit 8.30
Net Profit Margin (%) 4.45
Earnings Per Share (EPS) 1.66
EBITDA 13.68
Effective Tax Rate (%) 24.20
Particulars MAR 2025 (Values in Cr)
Revenue 198.14
Operating Expense 182.25
Net Profit 12.46
Net Profit Margin (%) 6.28
Earnings Per Share (EPS) 2.49
EBITDA 20.07
Effective Tax Rate (%) 27.89
Particulars MAR 2026 (Values in Cr)
Revenue 771.66
Operating Expense 721.79
Net Profit 41.05
Net Profit Margin (%) 5.31
Earnings Per Share (EPS) 4.10
EBITDA 66.07
Effective Tax Rate (%) 24.30
Particulars MAR 2025 (Values in Cr)
Revenue 661.51
Operating Expense 609.97
Net Profit 47.35
Net Profit Margin (%) 7.15
Earnings Per Share (EPS) 9.45
EBITDA 70.36
Effective Tax Rate (%) 22.37
Particulars MAR 2024 (Values in Cr)
Revenue 647.00
Operating Expense 580.79
Net Profit 60.06
Net Profit Margin (%) 9.28
Earnings Per Share (EPS) 11.98
EBITDA 87.24
Effective Tax Rate (%) 23.30
Particulars MAR 2023 (Values in Cr)
Revenue 527.49
Operating Expense 486.13
Net Profit 36.18
Net Profit Margin (%) 6.85
Earnings Per Share (EPS) 7.22
EBITDA 57.39
Effective Tax Rate (%) 23.78
Particulars MAR 2022 (Values in Cr)
Revenue 486.65
Operating Expense 452.71
Net Profit 30.56
Net Profit Margin (%) 6.27
Earnings Per Share (EPS) 6.10
EBITDA 52.04
Effective Tax Rate (%) 21.88
Particulars MAR 2025 (Values in Cr)
Book Value / Share 65.06
ROE % 13.41
ROCE % 17.15
Total Debt to Total Equity 0.02
EBITDA Margin 9.54
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.11
ROE % 19.49
ROCE % 25.44
Total Debt to Total Equity 0.01
EBITDA Margin 11.92
Particulars MAR 2023 (Values in Cr)
Book Value / Share 48.14
ROE % 15.90
ROCE % 20.82
Total Debt to Total Equity 0.01
EBITDA Margin 10.98
Particulars MAR 2022 (Values in Cr)
Book Value / Share 42.66
ROE % 15.11
ROCE % 19.14
Total Debt to Total Equity 0.04
EBITDA Margin 10.82
Particulars MAR 2021 (Values in Cr)
Book Value / Share 38.04
ROE % 12.75
ROCE % 15.72
Total Debt to Total Equity 0.17
EBITDA Margin 11.03
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 19.73
Total Assets 506.62
Total Liabilities 506.62
Total Equity 326.02
Share Outstanding 5
Price to Book Ratio 2.29
Return on Assets (%) 9.34
Return on Capital (%) 14.07
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.37
Total Assets 445.68
Total Liabilities 445.68
Total Equity 291.21
Share Outstanding 5
Price to Book Ratio 4.23
Return on Assets (%) 13.47
Return on Capital (%) 20.48
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.65
Total Assets 404.98
Total Liabilities 404.98
Total Equity 241.22
Share Outstanding 5
Price to Book Ratio 1.65
Return on Assets (%) 8.93
Return on Capital (%) 15
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 15.94
Total Assets 347.17
Total Liabilities 347.17
Total Equity 213.77
Share Outstanding 5
Price to Book Ratio 2.01
Return on Assets (%) 8.80
Return on Capital (%) 14.09
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 20.09
Total Assets 332.63
Total Liabilities 332.63
Total Equity 190.64
Share Outstanding 5
Price to Book Ratio 2.37
Return on Assets (%) 8.54
Return on Capital (%) 13.92
Particulars MAR 2025 (Values in Cr)
Net Income 61.00
Cash from Operations 48.24
Cash from Investing -19.90
Cash from Financing -4.85
Net change in Cash 12.35
Free Cash Flow 68.39
Particulars MAR 2024 (Values in Cr)
Net Income 78.30
Cash from Operations 31.99
Cash from Investing 0.91
Cash from Financing -8.56
Net change in Cash 5.27
Free Cash Flow 37.01
Particulars MAR 2023 (Values in Cr)
Net Income 47.47
Cash from Operations 67.36
Cash from Investing -43.48
Cash from Financing -12.28
Net change in Cash -1.86
Free Cash Flow 68.91
Particulars MAR 2022 (Values in Cr)
Net Income 39.12
Cash from Operations 38.00
Cash from Investing -7.81
Cash from Financing -19.44
Net change in Cash 1.59
Free Cash Flow 39.61
Particulars MAR 2021 (Values in Cr)
Net Income 38.55
Cash from Operations -9.00
Cash from Investing 52.20
Cash from Financing -33.11
Net change in Cash 0.35
Free Cash Flow -2.85
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.14 1.53 243.69 23.12 38.85
BLISS GVS PHARMA LTD. 486.60 39.50 4.32 5160.70 118.35 493.70
CIPLA LTD 1353.85 28.73 3.17 109370.14 1165.55 1672.20
FERMENTA BIOTECH LIMITED 338.20 14.92 2.44 995.36 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2332.85 41.07 17.42 39519.89 2088.00 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 546.70 24.50 4.26 1580.54 490.00 789.95
ASTRAZENECA PHARMA IND LT 8406.60 109.79 24.07 21016.50 7630.00 9850.00
BLISS GVS PHARMA LTD. 486.60 52.49 4.46 5160.70 118.35 493.70

ANUH PHARMA LIMITED shareholding pattern

Holding
28.15%
71.79%
0.04%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

ANUH PHARMA LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
77.60 -1.64 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 78.50
  • 26 Days 78.00
  • 10 Days 78.20
  • 50 Days 78.10
  • 12 Days 78.10
  • 100 Days 78.60
  • 20 Days 78.00
  • 200 Days 81.10
79.70 PIVOT
First Support 77.50 First Resistance 81.10 Second Support 76.10 Second Resistance 83.30 Third Support 73.90 Third Resistance 84.70
RSI 48.75 ADX 26.57 MACD 0.06 Williams % R -70.79 Commodity Channel Index (CCI) 28.27
Date 2026-06-19 Week 56150.00 Same Day 31342.00 Month 37125.00
1 Year 0.79 3 Year 0.89
Over 1 Month
-2.70% down
Over 1 Year
-25.30% down
Over 3 Months
4.45% down
Over 3 Years
0.00% down
Over 6 Months
-0.95% down
Over 5 Years
0.00% down

ANUH PHARMA LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
14 Aug 2025 1.5 Final 15 Aug 2025 Equity shares
16 Aug 2024 2.5 Final 16 Aug 2024 Equity shares
11 Aug 2023 2.0 Final 11 Aug 2023 Equity shares
03 Aug 2022 1.75 Final 05 Aug 2022 Equity shares
17 Aug 2021 1.5 Final 19 Aug 2021 Equity shares
05 Mar 2020 2.75 Interim 06 Mar 2020 Equity shares
14 Aug 2019 2.75 Final 19 Aug 2019 Equity shares
27 Jul 2018 2.75 Final 31 Jul 2018 Equity shares
15 Sep 2017 2.5 Final 19 Sep 2017 Equity shares
15 Sep 2016 0.5 Final 19 Sep 2016 Equity shares
22 Mar 2016 2.0 Interim 23 Mar 2016 Equity shares
01 Jul 2015 5.0 Final 03 Jul 2015 Equity shares
04 Sep 2014 2.0 Interim 08 Sep 2014 Equity shares
04 Sep 2014 6.5 Final 08 Sep 2014 Equity shares
07 Mar 2014 1.25 Special 10 Mar 2014 Equity shares
25 Jul 2013 6.0 Final 29 Jul 2013 Equity shares
16 Aug 2012 5.5 Final 20 Aug 2012 Equity shares
21 Sep 2011 5.0 Final 23 Sep 2011 Equity shares
22 Feb 2010 10.0 Interim 23 Feb 2010 Equity shares
09 Sep 2009 2.5 Special 11 Sep 2009 Equity shares
09 Sep 2009 9.0 Final 11 Sep 2009 Equity shares
04 Sep 2008 8.0 Final 08 Sep 2008 Equity shares
22 Mar 2007 7.0 Final 23 Mar 2007 Equity shares
21 Sep 2005 0.0 Final 23 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
15 Jul 2025 15 Jul 2025 1:1
21 Sep 2020 18 Sep 2020 1:1
06 Aug 2015 05 Aug 2015 2:1
29 Oct 2010 28 Oct 2010 2:1
07 Aug 2006 31 Jul 2006 1:1
16 Sep 1999 23 Aug 1999 1:1
28 Mar 1995 24 Feb 1995 3:1
Ex-Date Old FV NEW FV Record Date
31 Jul 2006 10.0 5.0 07 Aug 2006
Dividend date Dividend amount Dividend type Record date Instrument type
14 Aug 2025 1.5 Final 15 Aug 2025 Equity shares
16 Aug 2024 2.5 Final 16 Aug 2024 Equity shares
11 Aug 2023 2.0 Final 11 Aug 2023 Equity shares
03 Aug 2022 1.75 Final 05 Aug 2022 Equity shares
17 Aug 2021 1.5 Final 19 Aug 2021 Equity shares
05 Mar 2020 2.75 Interim 06 Mar 2020 Equity shares
14 Aug 2019 2.75 Final 19 Aug 2019 Equity shares
27 Jul 2018 2.75 Final 31 Jul 2018 Equity shares
15 Sep 2017 2.5 Final 19 Sep 2017 Equity shares
15 Sep 2016 0.5 Final 19 Sep 2016 Equity shares
22 Mar 2016 2.0 Interim 23 Mar 2016 Equity shares
01 Jul 2015 5.0 Final 03 Jul 2015 Equity shares
04 Sep 2014 2.0 Interim 08 Sep 2014 Equity shares
04 Sep 2014 6.5 Final 08 Sep 2014 Equity shares
07 Mar 2014 1.25 Special 10 Mar 2014 Equity shares
25 Jul 2013 6.0 Final 29 Jul 2013 Equity shares
16 Aug 2012 5.5 Final 20 Aug 2012 Equity shares
21 Sep 2011 5.0 Final 23 Sep 2011 Equity shares
22 Feb 2010 10.0 Interim 23 Feb 2010 Equity shares
09 Sep 2009 2.5 Special 11 Sep 2009 Equity shares
09 Sep 2009 9.0 Final 11 Sep 2009 Equity shares
04 Sep 2008 8.0 Final 08 Sep 2008 Equity shares
22 Mar 2007 7.0 Final 23 Mar 2007 Equity shares
21 Sep 2005 0.0 Final 23 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
15 Jul 2025 15 Jul 2025 1:1
21 Sep 2020 18 Sep 2020 1:1
06 Aug 2015 05 Aug 2015 2:1
29 Oct 2010 28 Oct 2010 2:1
07 Aug 2006 31 Jul 2006 1:1
16 Sep 1999 23 Aug 1999 1:1
28 Mar 1995 24 Feb 1995 3:1
Ex-Date Old FV NEW FV Record Date
31 Jul 2006 10.0 5.0 07 Aug 2006

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Anuh Pharma Ltd?

Answer Field

Anuh Pharma Ltd share price is for NSE ₹ 77.65 & for BSE ₹ 77.02 as on Jun 19 2026 03:29 PM.

What is the Market Cap of Anuh Pharma Ltd Share?

Answer Field

The market cap of Anuh Pharma Ltd for NSE ₹ 777.70 & for BSE ₹ 0.00 as on Jun 19 2026 03:29 PM.

What is the 52 Week High and Low of Anuh Pharma Ltd?

Answer Field

The 52 Week High and Low of Anuh Pharma Ltd for NSE is ₹ 114.84 and ₹ 67.00 and for BSE is ₹ 115.00 and ₹ 66.72.

What is 1 year return for Anuh Pharma Ltd?

Answer Field

The 1 year returns on the stock has been -25.30%.

What is the P/E Ratio of Anuh Pharma Ltd Share?

Answer Field

As on Jun 19 2026 03:29 PM the price-to-earnings (PE) ratio for Anuh Pharma Ltd share is 18.94.

What is the PB ratio of Anuh Pharma Ltd Share?

Answer Field

As on Jun 19 2026 03:29 PM, the price-to-book (PB) ratio for Anuh Pharma Ltd share is 35.14.

How to Buy Anuh Pharma Ltd Share?

Answer Field

You can trade in Anuh Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Anuh Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Anuh Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Anuh Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|